Skip to main content
OpenTrials

Clinical trial condition

Prostate Cancer Metastatic

Explore clinical trials studying Prostate Cancer Metastatic. Study availability and eligibility vary by location and protocol.

86 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Prostate Cancer Metastatic trial results

Completed

Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer

NCT03646162

Conditions
Prostate Cancer Metastatic
Locations
  • Gen1 Research Glendale, Arizona, United States
  • Tower Urology Los Angeles, California, United States
  • Urology of San Bernardino San Bernardino, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
View all 24 locations
View Trial Details
Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

NCT03739684

Conditions
Disease, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Tower Urology Los Angeles, California, United States
  • University of California San Francisco - Helen Diller Cancer Center San Francisco, California, United States
  • Stanford Stanford, California, United States
View all 14 locations
View Trial Details
Completed

A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

NCT02407054

Conditions
Prostate Cancer Metastatic
Locations
  • Urology Centers of Alabama, P.C. Homewood, Alabama, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Prostate Oncology Specialists Marina del Rey, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 36 locations
View Trial Details
Completed

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

NCT03490032

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations
  • Pheonix Molecular Imaging Center Phoenix, Arizona, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Smilow Cancer Center at Yale New Haven New Haven, Connecticut, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Ga-68-PSMA-11 in High-risk Prostate Cancer

NCT03362359

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • Friedrich-Alexander-Universität Erlangen Erlangen, Germany
  • Universität Duisburg-Essen Essen, Germany
View Trial Details
Completed

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

NCT01322490

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Alaska Clinical Research Center, Llc Anchorage, Alaska, United States
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 220 locations
View Trial Details
Completed

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

NCT01487863

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • UCSD Medical Center - La Jolla La Jolla, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • Cancer Center Oncology Medical Group La Mesa, California, United States
  • UCSD Medical Center - Hillcrest San Diego, California, United States
View all 21 locations
View Trial Details
Completed

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT01718353

Conditions
Prostate Cancer Metastatic
Locations
  • Investigational Site Number 840003 Birmingham, Alabama, United States
  • Investigational Site Number 840102 Washington D.C., District of Columbia, United States
  • Investigational Site Number 840005 Indianapolis, Indiana, United States
  • Investigational Site Number 840025 Metairie, Louisiana, United States
View all 19 locations
View Trial Details

Related conditions